23 . June , 2018 - Saturday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Posaconazole

Big Image Pronouncation: (POE-sa-KON-a-zole)
Class: Antifungal

Trade Names:
- Suspension, oral 40 mg/mL

Mechanism of Action


Blocks the synthesis of ergosterol, a key component of fungal cell membranes.



T max is approximately 3 to 5 h. Steady-state plasma concentrations are reached in 7 to 10 days.


Vd is 1,774 L, suggesting extensive extravascular distribution and penetration into body tissues. Posaconazole is over 98% protein bound, primarily to albumin.


Metabolism mainly involves glucuronide conjugation via uridine diphosphate glucuronidation.


Elimination is approximately 71% in feces and 13% in urine in up to 120 h. The mean t ½ is 35 h.

Indications and Usage

Prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections because of severe immunocompromise; treatment of oropharyngeal candidiasis refractory to itraconazole and/or fluconazole.


Coadministration of ergot derivatives; coadministration with CYP3A4 substrates, including cisapride, halofantrine, pimozide, or quinidine; hypersensitivity to any component of the product.

Dosage and Administration

Prophylaxis of Invasive Fungal Infections
Adults and children 13 yr of age and older

PO 200 mg tid. The duration is based on recovery from neutropenia or immunosuppression.

Oropharyngeal Candidiasis
Adults and children 13 yr of age and older

PO Start with a loading dose of 100 mg bid on the first day, then 100 mg once daily for 13 days.

Oropharyngeal Candidiasis Refractory to Itraconazole and/or Fluconazole
Adults and children 13 yr of age and older

PO 400 mg bid. Duration based on severity of the underlying disease and clinical response.

General Advice

  • Shake oral suspension well before using.
  • Administer with a full meal or liquid nutritional supplement.
  • A measured dosing spoon marked for 2.5 and 5 mL doses is provided.


Store at 59° to 86°F. Do not freeze.

Drug Interactions

Calcium channel blockers metabolized through CYP3A4

Posaconazole may elevate plasma levels of these agents, increasing the risk of toxicity.

Cimetidine, phenytoin, rifabutin

Posaconazole plasma levels may be decreased; if possible, avoid coadministration.

Cyclosporine, sirolimus, tacrolimus

Plasma levels of these drugs may be elevated by posaconazole, increasing the risk of serious adverse reactions, including nephrotoxicity.

CYP3A4 substrates astemizole, cisapride, halofantrine, pimozide, quinidine, or terfenadine

Plasma levels of these agents may be elevated by posaconazole, leading to QTc prolongation and increasing the risk of life-threatening cardiac arrhythmias, including torsades de pointes. Coadministration with posaconazole is contraindicated.

Ergot derivatives

Plasma levels may be elevated by posaconazole, increasing the risk of ergotism. Coadministration with posaconazole is contraindicated.

HMG-CoA reductase inhibitors (statins) metabolized through CYP3A4

Posaconazole may elevate plasma levels of these agents, increasing the risk of adverse reactions (eg, rhabdomyolysis). Statin dose reduction is recommended.

Midazolam, phenytoin, rifabutin

Plasma concentrations of these drugs may be elevated by posaconazole.

Vinca alkaloids

Plasma concentrations may be elevated by posaconazole, increasing the risk of neurotoxicity.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Hypertension (18%); hypotension (14%); tachycardia (12%); QT/QTc prolongation (4%).


Headache (28%); fatigue, insomnia (17%); dizziness (11%); anxiety (9%); weakness (8%); asthenia (2%); somnolence, tremor (1%).


Rash (19%); pruritus (11%); increased sweating (2%).


Pharyngitis (12%); blurred vision, taste perversion (1%).


Diarrhea (42%); nausea (38%); vomiting (29%); abdominal pain (27%); constipation (21%); mucositis (17%); anorexia (15%); dyspepsia (10%); dry mouth, flatulence (1%).


Vaginal hemorrhage (10%); increased blood creatinine (2%).


Bilirubinemia (10%); increased ALT, AST, or gamma-glutamyl transferase (3%); hepatitis (1%).


Thrombocytopenia (29%); anemia (25%); neutropenia (23%); febrile neutropenia (20%); petechiae (11%).


Hypokalemia (30%); hypomagnesemia (18%); hyperglycemia (11%); increased alkaline phosphatase (2%); decreased weight, dehydration (1%).


Rigors (20%); musculoskeletal pain (16%); arthralgia (11%); back pain (10%).


Coughing (24%); dyspnea (20%); epistaxis (14%); upper respiratory tract infection (7%); pneumonia (3%).


Fever (45%); bacteremia (18%); herpes simplex, leg edema (15%); cytomegalovirus infection (14%); edema (9%); oral candidiasis (1%).



Monitor patients who have severe renal function impairment, severe diarrhea, or vomiting for breakthrough fungal infections. Monitor patients who develop abnormal LFTs during therapy for development of more severe hepatic injury.


Category C .




Safety and efficacy not established in children younger than 13 yr of age.


Because there is no information regarding cross-sensitivity with other azole antifungal agents, use with caution in patients with hypersensitivity to other azoles.



No adverse reactions were noted with doses up to 1,600 mg/day.

Patient Information

  • Advise patient to read the patient information leaflet before using product the first time and with each refill.
  • Explain name, dose, action, possible drug interactions, and potential adverse reactions of the drug.
  • Obtain patient history, including drug history and any known allergies.
  • Instruct patient to take exactly as prescribed and not to change the dose or discontinue therapy unless advised by health care provider.
  • Instruct patient to take this medication with a full meal or liquid nutritional supplement.
  • Advise patient to inform health care provider if severe diarrhea or vomiting develops because these conditions may change blood levels of the drug.
  • Caution patient to not take any prescription or OTC medications, herbal preparations, or dietary supplements unless advised by health care provider.
  • Advise women to notify health care provider if pregnant, planning to become pregnant, or breast-feeding.
  • Advise patient that follow-up visits may be necessary and to keep appointments.

Recent Drug Updates at DrugIndexOnline:

Angiotensin-Converting Enzyme (Ace) Inhibitors And Hydrochlorothiazide Angiotensin-Converting Enzyme (Ace) Inhibitors And Hydrochlorothiazide
Some commonly used brand names are: In the U.S.— Accuretic 6 Capozide 2 Lotensin HCT 1 Prinzide 4 Uniretic 5 Vaseretic 3 Zestoretic 4 In Canada— Accuretic 6 Prinzide 4 Vaseretic 3 Zestoretic 4 Note: For quick reference, the following medicines are numbered to match the corre more...

Folvite Folvite
Some commonly used brand names are: In the U.S.— Folvite In Canada— Apo-Folic Folvite Novo-Folacid Generic name product may be available in the U.S. and Canada. Another commonly used name is Vitamin B 9 . Category Diagnostic aid, folate deficiency Nutritional supplement, vita more...

Inversine Inversine
Some commonly used brand names are: In the U.S.— Inversine † Not commercially available in Canada. Category Antihypertensive Description Mecamylamine (mek-a-MILL-a-meen) belongs to the general class of medicines called antihypertensives. It is used to treat high blood pres more...

Nu-Metformin Nu-Metformin
Some commonly used brand names are: In the U.S.— Glucophage Glucophage XR Glumetza In Canada— Apo-Metformin Gen-Metformin Glucophage Glycon Novo-Metformin Nu-Metformin Category Antihyperglycemic agent Description Metformin (met-FOR-min) is used to treat a type of diabetes more...

Olopatadine Hydrochloride Olopatadine Hydrochloride
Pronouncation: (oh-low-pat-AD-een HIGH-droe-KLOR-ide) Class: Ophthalmic antihistamine Trade Names: Patanol - Solution 0.1% Mechanism of Action Pharmacology Inhibits release of histamine from mast cells and relatively selective histamine H1 antagonist. Inhibits type 1 immediate hypersensitivi more...

Optivar Optivar
Generic Name: azelastine ophthalmic (ah ZEL as tine) Brand Names: Optivar What is Optivar (azelastine ophthalmic)? Azelastine is an anti-allergic medication. It inhibits processes in the body that cause allergic symptoms after exposure to an allergen. Azelastine ophthalmic is used to tr more...

Peginterferon Alfa-2a Peginterferon Alfa-2a
Some commonly used brand names are: In the U.S.— Pegasys Category Biological response modifier Description Peginterferon alfa-2a (peg in-ter-FEER-on alf-a 2a) is a synthetic (man-made) version of substances normally produced in the body to fight infection. Peginterferon alfa-2a i more...

Pirbuterol Pirbuterol
Generic Name: Pirbuterol (peer-BYOO-ter-ole) Brand Name: Maxair AutohalerPirbuterol is used for:Treating or preventing the symptoms of asthma. It may be used alone or in combination with other medicines. It may also be used for other conditions as determined by your doctor. Pirbuterol is a bet more...